Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deutsche Bank downgrades Wetherspoons to 'sell'

(Sharecast News) - Deutsche Bank downgraded its stance on shares of pub group JD Wetherspoon to 'sell' from 'neutral' on Wednesday, slashing the price target to 450p from 600p following interim results. The bank pointed to the impact of changes related to the government's budget last October, which involved an increase in national insurance contributions and increases in the minimum wage and national living wage, which come into effect in April.

The national living wage is due to rise by 7%, while the national minimum wage is set to rise by 16%.

The bank said the changes were an "exogenous event", comparable to major events such as the UK smoking ban and the global financial crisis.

"Current sales momentum...implies a material shortfall versus the 7% cost growth we forecast for the sector," DB said.

"Similarly, supermarkets are passing less on to consumers (via price) owing to higher labour productivity.

"We would continue to avoid labour-intensive businesses with thin operating margins."

In the same note, Deutsche Bank said it was also remaining cautious on 'sell' rated Greggs.

At 1355 GMT, JDW shares were down 1.1% at 563.56p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.